China Medical Cannabis Market Report & Forecast 2021-2027

Publisher Name :
Date: 15-Nov-2021
No. of pages: 90
Inquire Before Buying

China Medical Cannabis Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)

China Medical Cannabis Market Segment Percentages, By Type, 2020 (%)

- Tetrahydrocannabinol (THC)

- Cannabidiol (CBD)

China Medical Cannabis Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)

China Medical Cannabis Market Segment Percentages, By Application, 2020 (%)

- Pain

- Arthritis

- Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Medical Cannabis revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Medical Cannabis revenues share in China market, 2020 (%)

Key companies Medical Cannabis sales in China market, 2016-2021 (Estimated), (MT)

Key companies Medical Cannabis sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- BOL Pharma

- Tilray

- Medreleaf Corporation

- Aurora Cannabis, Inc

- Canopy Growth Corporation

- Insys Therapeutics, Inc

- Aphria, Inc

- MGC Pharmaceuticals Limited

- GW Pharmaceuticals, plc

- Medical Marijuana Inc

- Medipharm Labs

China Medical Cannabis Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Medical Cannabis Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Medical Cannabis Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Medical Cannabis Overall Market Size
2.1 China Medical Cannabis Market Size: 2021 VS 2027
2.2 China Medical Cannabis Revenue, Prospects & Forecasts: 2016-2027
2.3 China Medical Cannabis Sales: 2016-2027
3 Company Landscape
3.1 Top Medical Cannabis Players in China Market
3.2 Top China Medical Cannabis Companies Ranked by Revenue
3.3 China Medical Cannabis Revenue by Companies
3.4 China Medical Cannabis Sales by Companies
3.5 China Medical Cannabis Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Medical Cannabis Companies in China Market, by Revenue in 2020
3.7 Manufacturers Medical Cannabis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical Cannabis Players in China Market
3.8.1 List of Tier 1 Medical Cannabis Companies in China
3.8.2 List of Tier 2 and Tier 3 Medical Cannabis Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Medical Cannabis Market Size Markets, 2021 & 2027
4.1.2 Tetrahydrocannabinol (THC)
4.1.3 Cannabidiol (CBD)
4.2 By Type - China Medical Cannabis Revenue & Forecasts
4.2.1 By Type - China Medical Cannabis Revenue, 2016-2021
4.2.2 By Type - China Medical Cannabis Revenue, 2022-2027
4.2.3 By Type - China Medical Cannabis Revenue Market Share, 2016-2027
4.3 By Type - China Medical Cannabis Sales & Forecasts
4.3.1 By Type - China Medical Cannabis Sales, 2016-2021
4.3.2 By Type - China Medical Cannabis Sales, 2022-2027
4.3.3 By Type - China Medical Cannabis Sales Market Share, 2016-2027
4.4 By Type - China Medical Cannabis Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Medical Cannabis Market Size, 2021 & 2027
5.1.2 Pain
5.1.3 Arthritis
5.1.4 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
5.1.5 Others
5.2 By Application - China Medical Cannabis Revenue & Forecasts
5.2.1 By Application - China Medical Cannabis Revenue, 2016-2021
5.2.2 By Application - China Medical Cannabis Revenue, 2022-2027
5.2.3 By Application - China Medical Cannabis Revenue Market Share, 2016-2027
5.3 By Application - China Medical Cannabis Sales & Forecasts
5.3.1 By Application - China Medical Cannabis Sales, 2016-2021
5.3.2 By Application - China Medical Cannabis Sales, 2022-2027
5.3.3 By Application - China Medical Cannabis Sales Market Share, 2016-2027
5.4 By Application - China Medical Cannabis Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 BOL Pharma
6.1.1 BOL Pharma Corporation Information
6.1.2 BOL Pharma Overview
6.1.3 BOL Pharma Medical Cannabis Sales and Revenue in China Market (2016-2021)
6.1.4 BOL Pharma Medical Cannabis Product Description
6.1.5 BOL Pharma Recent Developments
6.2 Tilray
6.2.1 Tilray Corporation Information
6.2.2 Tilray Overview
6.2.3 Tilray Medical Cannabis Sales and Revenue in China Market (2016-2021)
6.2.4 Tilray Medical Cannabis Product Description
6.2.5 Tilray Recent Developments
6.3 Medreleaf Corporation
6.3.1 Medreleaf Corporation Corporation Information
6.3.2 Medreleaf Corporation Overview
6.3.3 Medreleaf Corporation Medical Cannabis Sales and Revenue in China Market (2016-2021)
6.3.4 Medreleaf Corporation Medical Cannabis Product Description
6.3.5 Medreleaf Corporation Recent Developments
6.4 Aurora Cannabis, Inc
6.4.1 Aurora Cannabis, Inc Corporation Information
6.4.2 Aurora Cannabis, Inc Overview
6.4.3 Aurora Cannabis, Inc Medical Cannabis Sales and Revenue in China Market (2016-2021)
6.4.4 Aurora Cannabis, Inc Medical Cannabis Product Description
6.4.5 Aurora Cannabis, Inc Recent Developments
6.5 Canopy Growth Corporation
6.5.1 Canopy Growth Corporation Corporation Information
6.5.2 Canopy Growth Corporation Overview
6.5.3 Canopy Growth Corporation Medical Cannabis Sales and Revenue in China Market (2016-2021)
6.5.4 Canopy Growth Corporation Medical Cannabis Product Description
6.5.5 Canopy Growth Corporation Recent Developments
6.6 Insys Therapeutics, Inc
6.6.1 Insys Therapeutics, Inc Corporation Information
6.6.2 Insys Therapeutics, Inc Overview
6.6.3 Insys Therapeutics, Inc Medical Cannabis Sales and Revenue in China Market (2016-2021)
6.6.4 Insys Therapeutics, Inc Medical Cannabis Product Description
6.6.5 Insys Therapeutics, Inc Recent Developments
6.7 Aphria, Inc
6.7.1 Aphria, Inc Corporation Information
6.7.2 Aphria, Inc Overview
6.7.3 Aphria, Inc Medical Cannabis Sales and Revenue in China Market (2016-2021)
6.7.4 Aphria, Inc Medical Cannabis Product Description
6.7.5 Aphria, Inc Recent Developments
6.8 MGC Pharmaceuticals Limited
6.8.1 MGC Pharmaceuticals Limited Corporation Information
6.8.2 MGC Pharmaceuticals Limited Overview
6.8.3 MGC Pharmaceuticals Limited Medical Cannabis Sales and Revenue in China Market (2016-2021)
6.8.4 MGC Pharmaceuticals Limited Medical Cannabis Product Description
6.8.5 MGC Pharmaceuticals Limited Recent Developments
6.9 GW Pharmaceuticals, plc
6.9.1 GW Pharmaceuticals, plc Corporation Information
6.9.2 GW Pharmaceuticals, plc Overview
6.9.3 GW Pharmaceuticals, plc Medical Cannabis Sales and Revenue in China Market (2016-2021)
6.9.4 GW Pharmaceuticals, plc Medical Cannabis Product Description
6.9.5 GW Pharmaceuticals, plc Recent Developments
6.10 Medical Marijuana Inc
6.10.1 Medical Marijuana Inc Corporation Information
6.10.2 Medical Marijuana Inc Overview
6.10.3 Medical Marijuana Inc Medical Cannabis Sales and Revenue in China Market (2016-2021)
6.10.4 Medical Marijuana Inc Medical Cannabis Product Description
6.10.5 Medical Marijuana Inc Recent Developments
6.11 Medipharm Labs
6.11.1 Medipharm Labs Corporation Information
6.11.2 Medipharm Labs Overview
6.11.3 Medipharm Labs Medical Cannabis Sales and Revenue in China Market (2016-2021)
6.11.4 Medipharm Labs Medical Cannabis Product Description
6.11.5 Medipharm Labs Recent Developments
7 China Medical Cannabis Production Capacity, Analysis
7.1 China Medical Cannabis Production Capacity, 2016-2027
7.2 Medical Cannabis Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Medical Cannabis Supply Chain Analysis
9.1 Medical Cannabis Industry Value Chain
9.2 Medical Cannabis Upstream Market
9.3 Medical Cannabis Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Medical Cannabis Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Medical Cannabis in China Market
Table 2. Top Medical Cannabis Players in China Market, Ranking by Revenue (2019)
Table 3. China Medical Cannabis Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Medical Cannabis Revenue Share by Companies, 2016-2021
Table 5. China Medical Cannabis Sales by Companies, (MT), 2016-2021
Table 6. China Medical Cannabis Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Medical Cannabis Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Medical Cannabis Product Type
Table 9. List of Tier 1 Medical Cannabis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Medical Cannabis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Tetrahydrocannabinol (THC)
Table 12. Major Manufacturers of Cannabidiol (CBD)
Table 13. By Type - China Medical Cannabis Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Medical Cannabis Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Medical Cannabis Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Medical Cannabis Sales (MT), 2016-2021
Table 17. By Type - China Medical Cannabis Sales (MT), 2022-2027
Table 18. By Application - China Medical Cannabis Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Medical Cannabis Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Medical Cannabis Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Medical Cannabis Sales (MT), 2016-2021
Table 22. By Application - China Medical Cannabis Sales (MT), 2022-2027
Table 23. BOL Pharma Corporation Information
Table 24. BOL Pharma Description and Major Businesses
Table 25. BOL Pharma Medical Cannabis Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. BOL Pharma Medical Cannabis Product
Table 27. BOL Pharma Recent Developments
Table 28. Tilray Corporation Information
Table 29. Tilray Description and Major Businesses
Table 30. Tilray Medical Cannabis Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. Tilray Medical Cannabis Product
Table 32. Tilray Recent Developments
Table 33. Medreleaf Corporation Corporation Information
Table 34. Medreleaf Corporation Description and Major Businesses
Table 35. Medreleaf Corporation Medical Cannabis Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. Medreleaf Corporation Medical Cannabis Product
Table 37. Medreleaf Corporation Recent Developments
Table 38. Aurora Cannabis, Inc Corporation Information
Table 39. Aurora Cannabis, Inc Description and Major Businesses
Table 40. Aurora Cannabis, Inc Medical Cannabis Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. Aurora Cannabis, Inc Medical Cannabis Product
Table 42. Aurora Cannabis, Inc Recent Developments
Table 43. Canopy Growth Corporation Corporation Information
Table 44. Canopy Growth Corporation Description and Major Businesses
Table 45. Canopy Growth Corporation Medical Cannabis Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 46. Canopy Growth Corporation Medical Cannabis Product
Table 47. Canopy Growth Corporation Recent Developments
Table 48. Insys Therapeutics, Inc Corporation Information
Table 49. Insys Therapeutics, Inc Description and Major Businesses
Table 50. Insys Therapeutics, Inc Medical Cannabis Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 51. Insys Therapeutics, Inc Medical Cannabis Product
Table 52. Insys Therapeutics, Inc Recent Developments
Table 53. Aphria, Inc Corporation Information
Table 54. Aphria, Inc Description and Major Businesses
Table 55. Aphria, Inc Medical Cannabis Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 56. Aphria, Inc Medical Cannabis Product
Table 57. Aphria, Inc Recent Developments
Table 58. MGC Pharmaceuticals Limited Corporation Information
Table 59. MGC Pharmaceuticals Limited Description and Major Businesses
Table 60. MGC Pharmaceuticals Limited Medical Cannabis Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 61. MGC Pharmaceuticals Limited Medical Cannabis Product
Table 62. MGC Pharmaceuticals Limited Recent Developments
Table 63. GW Pharmaceuticals, plc Corporation Information
Table 64. GW Pharmaceuticals, plc Description and Major Businesses
Table 65. GW Pharmaceuticals, plc Medical Cannabis Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 66. GW Pharmaceuticals, plc Medical Cannabis Product
Table 67. GW Pharmaceuticals, plc Recent Developments
Table 68. Medical Marijuana Inc Corporation Information
Table 69. Medical Marijuana Inc Description and Major Businesses
Table 70. Medical Marijuana Inc Medical Cannabis Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 71. Medical Marijuana Inc Medical Cannabis Product
Table 72. Medical Marijuana Inc Recent Developments
Table 73. Medipharm Labs Corporation Information
Table 74. Medipharm Labs Description and Major Businesses
Table 75. Medipharm Labs Medical Cannabis Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 76. Medipharm Labs Medical Cannabis Product
Table 77. Medipharm Labs Recent Developments
Table 78. Medical Cannabis Production Capacity (MT) of Key Manufacturers in China Market, 2019-2021 (MT)
Table 79. China Medical Cannabis Capacity Market Share of Key Manufacturers, 2019-2021
Table 80. Medical Cannabis Market Opportunities & Trends in China Market
Table 81. Medical Cannabis Market Drivers in China Market
Table 82. Medical Cannabis Market Restraints in China Market
Table 83. Medical Cannabis Raw Materials
Table 84. Medical Cannabis Raw Materials Suppliers in China Market
Table 85. Typical Medical Cannabis Downstream
Table 86. Medical Cannabis Downstream Clients in China Market
Table 87. Medical Cannabis Distributors and Sales Agents in China Market
List of Figures
Figure 1. Medical Cannabis Product Picture
Figure 2. Medical Cannabis Segment by Type
Figure 3. Medical Cannabis Segment by Application
Figure 4. China Medical Cannabis Market Overview: 2020
Figure 5. China Medical Cannabis Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Medical Cannabis Revenue, 2016-2027 (US$, Mn)
Figure 7. Medical Cannabis Sales in China Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Medical Cannabis Revenue in 2020
Figure 9. Tetrahydrocannabinol (THC) Product Picture
Figure 10. Cannabidiol (CBD) Product Picture
Figure 11. By Type - China Medical Cannabis Sales Market Share, 2016-2027
Figure 12. By Type - China Medical Cannabis Revenue Market Share, 2016-2027
Figure 13. By Type - China Medical Cannabis Price (USD/MT), 2016-2027
Figure 14. Pain
Figure 15. Arthritis
Figure 16. Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
Figure 17. Others
Figure 18. By Application - China Medical Cannabis Sales Market Share, 2016-2027
Figure 19. By Application - China Medical Cannabis Revenue Market Share, 2016-2027
Figure 20. By Application - China Medical Cannabis Price (USD/MT), 2016-2027
Figure 21. BOL Pharma Medical Cannabis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Tilray Medical Cannabis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Medreleaf Corporation Medical Cannabis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Aurora Cannabis, Inc Medical Cannabis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Canopy Growth Corporation Medical Cannabis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Insys Therapeutics, Inc Medical Cannabis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Aphria, Inc Medical Cannabis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. MGC Pharmaceuticals Limited Medical Cannabis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. GW Pharmaceuticals, plc Medical Cannabis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Medical Marijuana Inc Medical Cannabis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Medipharm Labs Medical Cannabis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. China Medical Cannabis Production Capacity (MT), 2016-2027
Figure 33. Medical Cannabis Industry Value Chain
Figure 34. Marketing Channels
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs